PROBLEM
Today, the only reliable diagnosis of Alzheimer’s is post mortem identification of the disease in the brain.
SOLUTION
This innovation has developed an in vitro diagnostic method for early detection and differentiated diagnosis of Alzheimer’s disease.
NEW ANALYTICAL TOOL FOR ALZHEIMER’S
BioChromix products are based on an innovative and proprietary material that has been developed by the company. By combining it with traditional labware we can provide unique methods and products that enable analysis of the pathological events leading to Alzheimer’s disease (AD) with extremely high accuracy. BioChromix has thereby been able to deliver analytical tools for AD that can be used together with standard high sensitivity laboratory equipment. Other companies have tried and failed to produce the sought after molecular diagnostic tools for AD using conventional technologies, including antibodies and peptides. The BioChromix innovation is thus both a unique material and a novel approach to its application together with equipment normally found in biochemical laboratories.
